Table 3.
Hemorrhagic anemia in LCMV-infected mice requires IFN-α/β signaling
Treatment | Mouse strain | Platelets, 103/μl | Survival, % | Hct, % | RC, 103/μl | OAS BM |
---|---|---|---|---|---|---|
NaCl | C57BL/6J | 1,275 ± 53 | 100 | 47.7 ± 5.1 | 108 ± 9 | 1 |
α-Irr + LCMV | C57BL/6J | 265 ± 45 | 100 | 35.5 ± 2.2 | 46 ± 8 | 12.2 ± 1 |
α-PLT + LCMV | C57BL/6J | 12 ± 6 | 40 | 11.3 ± 4.2 | 41 ± 9 | 12.8 ± 1 |
NaCl | IFN-α/βR−/− | 1,218 ± 48 | 100 | 43.0 ± 2.6 | 197 ± 4 | und |
α-Irr + LCMV | IFN-α/βR−/− | 712 ± 39 | 100 | 40.2 ± 3.3 | 298 ± 2 | und |
α-PLT + LCMV | IFN-α/βR−/− | 19 ± 7 | 100 | 33.2 ± 2.8 | 1,171 ± 6 | und |
Platelet counts, survival rate, and Hct and RC values (mean ± SD) were assessed individually in groups of C57BL/6J or IFN-α /βR−/− mice (10 mice per group) at 6 days after injection of NaCl, α-Irr + LCMV, or α-PLT + LCMV (LCMV Arm given at 106 pfu per mouse). OAS expression was measured as Table 1.